Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM22F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,442
Award facts
- Contract value 100% obligated
- $31,441.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,441.84 delivery order to AmerisourceBergen Drug Corp for Vraylar 1.5 mg capsules (30-count units) on December 5, 2025, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vraylar is a prescription antipsychotic medication used to treat conditions such as bipolar disorder and schizophrenia, representing part of the Defense Logistics Agency's ongoing medical supply procurement for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. As a major pharmaceutical distributor and the prime contractor on this IDC, AmerisourceBergen Drug Corp supplies a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's federal contracting profile demonstrates consistent capability in delivering both brand-name and generic pharmaceuticals across multiple therapeutic domains through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FM22F?
SPE2DR26FM22F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FM22F worth?
The government has obligated $31,442 on SPE2DR26FM22F.
Is contract SPE2DR26FM22F an order under another contract?
Yes. SPE2DR26FM22F is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM22F competed?
The extent of competition for SPE2DR26FM22F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award